IQVIA Holdings Inc. (“IQVIA™”) (NYSE: IQV) has been named to the Forbes 2019 list of America’s Best Employers for Women. Forbes joined with market research firm Statista to identify the companies liked most by female employees based on various workplace criteria that included pay equity, diversity, family support, working conditions, and parental leave.
“We’re honored to be on the Forbes list of Best Employers for Women,” said IQVIA Chairman and CEO Ari Bousbib. “It’s the expertise and creativity of our talented employee base that advances our strategic vision to break new ground within the life sciences industry, drive healthcare innovation and accelerate transformation through disruptive technologies.”
The survey was conducted using several online access panels for companies across all industry sectors, excluding government services, to provide a representative sample of the U.S. workforce. The list was compiled from responses by 60,000 Americans, including 40,000 women, working for businesses with at least 1,000 employees at their U.S. operations. See recent honors presented to female leaders at IQVIA from within the healthcare industry here.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 61,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.